Growth Metrics

Nephros (NEPH) Operating Leases (2019 - 2026)

Nephros' quarterly Operating Leases came in at $566000.0 in Q1 2026, down 41.59% year-on-year from $969000.0 in Q1 2025, and down 15.77% quarter-over-quarter from $672000.0 in Q4 2025.

Nephros has reported Operating Leases for 8 years, with the latest figure at $566000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Operating Leases fell 41.59% year-over-year to $566000.0; the trailing twelve-month figure through Mar 2026 stood at $566000.0 (down 41.59% YoY), and the FY2025 full-year result was $672000.0, down 36.78% from the prior year.
  • Operating Leases for Q1 2026 stood at $566000.0, down from $672000.0 in the prior quarter.
  • The five-year high for Operating Leases was $1.4 million in Q4 2023, with the low at $201000.0 in Q3 2022.
  • Average Operating Leases over 5 years is $777941.2, with a median of $705000.0 recorded in 2022.
  • Year-over-year, Operating Leases surged 146.06% in 2024 and sank 41.59% in 2026.
  • Tracing NEPH's Operating Leases over 5 years: stood at $705000.0 in 2022, then jumped by 97.16% to $1.4 million in 2023, then declined by 23.53% to $1.1 million in 2024, then plunged by 36.78% to $672000.0 in 2025, then slipped by 15.77% to $566000.0 in 2026.
  • The last three Operating Leases figures came in at $566000.0 (Q1 2026), $672000.0 (Q4 2025), and $774000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Nephros 38.93 Mn 34.91 Mn 2.99 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 566,000.00
Dec 31, 2025 672,000.00
Sep 30, 2025 774,000.00
Jun 30, 2025 872,000.00
Mar 31, 2025 969,000.00
Dec 31, 2024 1.06 Mn
Sep 30, 2024 1.15 Mn
Jun 30, 2024 1.22 Mn
Mar 31, 2024 1.31 Mn
Dec 31, 2023 1.39 Mn
Sep 30, 2023 469,000.00
Jun 30, 2023 534,000.00
Mar 31, 2023 618,000.00
Dec 31, 2022 705,000.00
Sep 30, 2022 201,000.00
Jun 30, 2022 358,000.00
Mar 31, 2022 351,000.00
Dec 31, 2021 340,000.00
Dec 31, 2020 759,000.00
Sep 30, 2020 846,000.00
Jun 30, 2020 1.21 Mn
Mar 31, 2020 988,000.00
Dec 31, 2019 889,000.00
Sep 30, 2019 1.21 Mn
Jun 30, 2019 1.02 Mn
Mar 31, 2019 800,000.00